Insulin degludec: Lower day-to-day and within-day variability in pharmacodynamic response compared with insulin glargine 300 U/mL in type 1 diabetes
Author:
Affiliation:
1. Profil; Neuss Germany
2. Novo Nordisk A/S; Søborg Denmark
Funder
Novo Nordisk A/S
Publisher
Wiley
Subject
Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/dom.12938/fullpdf
Reference19 articles.
1. Old and new basal insulin formulations: understanding pharmacodynamics is still relevant in clinical practice;Rossetti;Diabetes Obes Metab,2014
2. Impact of the mode of protraction of basal insulin therapies on their pharmacokinetic and pharmacodynamic properties and resulting clinical outcomes;Heise;Diabetes Obes Metab,2017
3. A review of the pharmacological properties of insulin degludec and their clinical relevance;Haahr;Clin Pharmacokinet,2014
4. Lower within-subject variability of insulin detemir in comparison to NPH insulin and insulin glargine in people with type 1 diabetes;Heise;Diabetes,2004
5. Insulin degludec: four times lower pharmacodynamic variability than insulin glargine under steady-state conditions in type 1 diabetes;Heise;Diabetes Obes Metab,2012
Cited by 106 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Continuous Glucose Monitoring-Derived Glucometrics in Adults with Type 1 Diabetes When Switching Basal Insulins;Diabetes Technology & Therapeutics;2024-08-01
2. Insulin Analogs and the Mode of Insulin Delivery: Recent Advances and Challenges;Current Pharmaceutical Biotechnology;2024-04-02
3. Effects of Switching from Degludec to Glargine U300 in Patients with Insulin-Dependent Type 1 Diabetes: A Retrospective Study;Medicina;2024-03-08
4. Insulin Degludec in People with Type 2 Diabetes in China: A Non-interventional, Retrospective Chart Review Study (CN-TREAT);Diabetes Therapy;2024-03
5. Evolution of insulin therapy: past, present, future;Problems of Endocrinology;2024-01-24
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3